Cargando…
GSK3 inhibition rescues growth and telomere dysfunction in dyskeratosis congenita iPSC-derived type II alveolar epithelial cells
Dyskeratosis congenita (DC) is a rare genetic disorder characterized by deficiencies in telomere maintenance leading to very short telomeres and the premature onset of certain age-related diseases, including pulmonary fibrosis (PF). PF is thought to derive from epithelial failure, particularly that...
Autores principales: | Fernandez, Rafael Jesus, Gardner, Zachary JG, Slovik, Katherine J, Liberti, Derek C, Estep, Katrina N, Yang, Wenli, Chen, Qijun, Santini, Garrett T, Perez, Javier V, Root, Sarah, Bhatia, Ranvir, Tobias, John W, Babu, Apoorva, Morley, Michael P, Frank, David B, Morrisey, Edward E, Lengner, Christopher J, Johnson, F Brad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200405/ https://www.ncbi.nlm.nih.gov/pubmed/35559731 http://dx.doi.org/10.7554/eLife.64430 |
Ejemplares similares
-
Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes
por: Balboa, Diego, et al.
Publicado: (2018) -
Skeletal dysplasia-causing TRPV4 mutations suppress the hypertrophic differentiation of human iPSC-derived chondrocytes
por: Dicks, Amanda R, et al.
Publicado: (2023) -
Dyskeratosis congenita
por: Gitto, Lorenzo, et al.
Publicado: (2020) -
Defining the role of pulmonary endothelial cell heterogeneity in the response to acute lung injury
por: Niethamer, Terren K, et al.
Publicado: (2020) -
Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita
por: Choo, Seunga, et al.
Publicado: (2022)